Our new Go-To-Market model has been implemented and early signs are encouraging, which is reflected in the strong performance of flagship brands and new launches
The company plans to launch 5-6 products in FY22.
New capacity in specialty care is to be commissioned in next 45 days.
Group sales amounted to around 10 billion euros, an increase of 4.7 percent in nominal terms
The company posted net loss Rs.(0.5513) crores for the period ended June 30, 2020.
The company posted net profit of Rs.29.33 crores for the period ended June 30, 2020.
The company posted net profit of Rs.1.80 crores for the period ended June 30, 2020.
The company posted net profit of Rs.19.20 crores for the period ended June 30, 2020.
It posted net loss of Rs.(5.07) crores for the period ended June 30, 2020.
The company posted net profit of Rs.69.86 crores for the period ended June 30, 2020.
The company posted net profit loss of Rs.(20.26) crores for the period ended June 30, 2020.
Adjusted EBITDA improves by 70.7% to €71.7 million
Novozymes delivered 9% organic sales growth in the second quarter and 6% organic sales growth in the first half of 2021.
The MOU with SK Global Chemical is designed to lead to the development of solvent-based recycling operations in Asia Pacific
Profit was down 7% to Rs 11.6 crore as compared to Rs. 12.5 crore in Q1 FY21 due to tax expense of Rs. 4.8 crore in Q1 FY22 compared to Rs. -5.4 crore in Q1 FY21
Dye Intermediates (DI) planned a capex of Rs. 85 crore to further expand the DI capacities to around 22,000 TPA
It posted net profit of Rs.2.97 crores for the period ended June 30, 2020.
The company posted net loss of Rs.(1.78) crores for the period ended June 30, 2020.
The company posted net profit of Rs.10 crores for the period ended June 30, 2020.
The company posted net of Rs.11.19 crores for the period ended June 30, 2020.
Subscribe To Our Newsletter & Stay Updated
